NCT00108992

Brief Summary

Oral non-steroidal anti-inflammatory drugs (NSAIDs) are a recommended treatment for the symptoms of osteoarthritis of the knee. However, NSAIDs may cause a range of negative side effects, including stomach pain, heartburn, bleeding stomach ulcer, and liver or kidney abnormality. A topical NSAID may relieve pain and other symptoms of osteoarthritis of the knee, while minimizing the side effects common to oral NSAIDs. The purpose of this study is to determine the safety and effectiveness of a topical NSAID when used alone or when combined with an oral NSAID in the treatment of osteoarthritis of the knee.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
750

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Feb 2004

Geographic Reach
1 country

22 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2004

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 21, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 22, 2005

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2005

Completed
Last Updated

January 5, 2007

Status Verified

January 1, 2007

First QC Date

April 21, 2005

Last Update Submit

January 4, 2007

Conditions

Keywords

topical NSAIDtopical diclofenac

Outcome Measures

Primary Outcomes (3)

  • pain

  • physical function

  • patient overall health assessment

Secondary Outcomes (2)

  • stiffness

  • patient global assessment

Interventions

Eligibility Criteria

Age40 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary osteoarthritis of the knee, verified radiographically
  • Moderate flare of pain in the knee after washout of stable therapy
  • If female, non-pregnant
  • Ability to swallow moderately-sized tablets

You may not qualify if:

  • Secondary osteoarthritis of the knee
  • Major knee surgery at any time, or minor knee surgery in previous year
  • Severe uncontrolled heart, liver or kidney disease
  • Ulcer or bleeding from the stomach
  • Corticosteroid use
  • Fibromyalgia
  • Skin disorder of the knee

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (22)

Coastal Clinical Research

Mobile, Alabama, 36608, United States

Location

Redpoint Research

Phoenix, Arizona, 85029, United States

Location

OMC Clinical

Beverly Hills, California, 90211, United States

Location

Associated Pharmaceutical Research

Buena Park, California, 90620, United States

Location

Med Investigators

Fair Oaks, California, 95628, United States

Location

Desert Medical Advances

Palm Desert, California, 92260, United States

Location

Boling Clinical Trials

Upland, California, 91786, United States

Location

Tampa Bay Medical Research Inc.

Clearwater, Florida, 33761, United States

Location

Palm Beach Research Center

West Palm Beach, Florida, 33409, United States

Location

Medisphere Medical Research

Evansville, Indiana, 47714, United States

Location

Synergy Medical Education Alliance

Saginaw, Michigan, 48602, United States

Location

Redrock Research Center

Las Vegas, Nevada, 89146, United States

Location

Partners in Primary Care

Voorhees Township, New Jersey, 08043, United States

Location

Camp Hill Clinical Research Center

Camp Hill, Pennsylvania, 17011, United States

Location

Primary Physicians Research

Pittsburgh, Pennsylvania, 15241, United States

Location

University Orthopedics Center

State College, Pennsylvania, 16801, United States

Location

Omega Medical Research

Warwick, Rhode Island, 02886, United States

Location

Clinical Research Associates

Nashville, Tennessee, 37203, United States

Location

Research Across America

Dallas, Texas, 75234, United States

Location

Sam Clinical Research Center

San Antonio, Texas, 78229, United States

Location

Hamptom Roads Center for Clinical Research

Norfolk, Virginia, 23502-9921, United States

Location

National Clinical Research

Richmond, Virginia, 23294, United States

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Diclofenac

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

PhenylacetatesAcids, CarbocyclicCarboxylic AcidsOrganic Chemicals

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

April 21, 2005

First Posted

April 22, 2005

Study Start

February 1, 2004

Study Completion

September 1, 2005

Last Updated

January 5, 2007

Record last verified: 2007-01

Locations